Impact of facility type and volume on survival in patients with metastatic renal cell carcinoma
CONCLUSIONS: Treatment at ACs and HVHs was associated with a survival benefit in patients with mRCC. Patients treated at AC were more likely to receive immunotherapy, undergo CN and metastasectomy.PMID:34657653
Source: Canadian Journal of Urology - Category: Urology & Nephrology Authors: Furkan Dursun Ahmed Elshabrawy Hanzhang Wang James Oelsen Michael Liss Dharam Kaushik Chethan Ramamurthy Ronald Rodriguez Ahmed M Mansour Source Type: research
More News: Academia | Canada Health | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Immunotherapy | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Urology & Nephrology